---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-131723"
form_type: "8-K"
ticker: "NWBO"
cik: "0001072379"
company_name: "NORTHWEST BIOTHERAPEUTICS INC"
filed_at: "2024-12-26T23:59:59+00:00"
generated_at: "2026-05-28T23:12:12.712291+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Northwest Biotherapeutics announces $5M convertible note and $50M standby equity facility

## Summary
- Entered $5M convertible promissory note with Yorkville, 13-month term, 7% original issue discount, no interest.
- Conversion at small discount to market price; limited to 1/6 of note per month unless conversion price above $0.315.
- Standby equity subscription agreement allows company to require Yorkville to buy up to $50M of common shares after note repaid/converted.
- Standby facility has 24-month term; no obligation to draw; company can cancel anytime after note repaid/converted.
- Proceeds for general corporate purposes; Joseph Gunnar & Co. acted as exclusive placement agent.

## SEC filing metadata
- accession: 0001104659-24-131723
- form_type: 8-K
- ticker: NWBO
- cik: 0001072379
- company_name: NORTHWEST BIOTHERAPEUTICS INC
- filed_at: 2024-12-26T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1072379/000110465924131723/0001104659-24-131723-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1072379/000110465924131723/tm2432020d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-131723
- JSON: https://secwatch.observer/filing/0001104659-24-131723.json
- Plain text: https://secwatch.observer/filing/0001104659-24-131723.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.